DEA schedule
Is propafenone a controlled substance?
Federal schedule for propafenone from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Propafenone is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and propafenone is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted propafenone?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 53 prescription listings from 14 labelers, none with a DEA schedule |
| DEA controlled substances list | propafenone is not on the list |
Propafenone NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0832-0740 | Propafenone Hydrochloride | capsule, extended release | 225 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 16571-736 | PROPAFENONE HYDROCHLORIDE | capsule, extended release | 225 mg/1 | Rising Pharma Holdings, Inc. | None |
| 16714-825 | propafenone hydrochloride | capsule, extended release | 225 mg/1 | Northstar Rx LLC | None |
| 59651-276 | Propafenone Hydrochloride | capsule, extended release | 225 mg/1 | Aurobindo Pharma Limited | None |
| 68382-522 | Propafenone Hydrochloride | capsule, extended release | 225 mg/1 | Zydus Pharmaceuticals (USA) Inc. | None |
| 68462-408 | propafenone hydrochloride | capsule, extended release | 225 mg/1 | Glenmark Pharmaceuticals Inc., USA | None |
| 69680-130 | Propafenone Hydrochloride | capsule, extended release | 225 mg/1 | Vitruvias Therapeutics | None |
| 70771-1525 | Propafenone Hydrochloride | capsule, extended release | 225 mg/1 | Zydus Lifesciences Limited | None |
| 0832-0741 | Propafenone Hydrochloride | capsule, extended release | 325 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 16571-737 | PROPAFENONE HYDROCHLORIDE | capsule, extended release | 325 mg/1 | Rising Pharma Holdings, Inc. | None |
| 16714-826 | propafenone hydrochloride | capsule, extended release | 325 mg/1 | Northstar Rx LLC | None |
| 59651-277 | Propafenone Hydrochloride | capsule, extended release | 325 mg/1 | Aurobindo Pharma Limited | None |
| 68382-523 | Propafenone Hydrochloride | capsule, extended release | 325 mg/1 | Zydus Pharmaceuticals (USA) Inc. | None |
| 68462-409 | propafenone hydrochloride | capsule, extended release | 325 mg/1 | Glenmark Pharmaceuticals Inc., USA | None |
| 69680-131 | Propafenone Hydrochloride | capsule, extended release | 325 mg/1 | Vitruvias Therapeutics | None |
| 70771-1526 | Propafenone Hydrochloride | capsule, extended release | 325 mg/1 | Zydus Lifesciences Limited | None |
| 0832-0742 | Propafenone Hydrochloride | capsule, extended release | 425 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 16571-738 | PROPAFENONE HYDROCHLORIDE | capsule, extended release | 425 mg/1 | Rising Pharma Holdings, Inc. | None |
| 16714-827 | propafenone hydrochloride | capsule, extended release | 425 mg/1 | Northstar Rx LLC | None |
| 59651-278 | Propafenone Hydrochloride | capsule, extended release | 425 mg/1 | Aurobindo Pharma Limited | None |
| 68382-524 | Propafenone Hydrochloride | capsule, extended release | 425 mg/1 | Zydus Pharmaceuticals (USA) Inc. | None |
| 68462-410 | propafenone hydrochloride | capsule, extended release | 425 mg/1 | Glenmark Pharmaceuticals Inc., USA | None |
| 69680-132 | Propafenone Hydrochloride | capsule, extended release | 425 mg/1 | Vitruvias Therapeutics | None |
| 70771-1527 | Propafenone Hydrochloride | capsule, extended release | 425 mg/1 | Zydus Lifesciences Limited | None |
| 51407-015 | Propafenone Hydrochloride | tablet, coated | 150 mg/1 | Golden State Medical Supply, Inc. | None |
| 62559-230 | Propafenone Hydrochloride | tablet, coated | 150 mg/1 | ANI Pharmaceuticals, Inc. | None |
| 63629-2105 | Propafenone Hydrochloride | tablet, coated | 150 mg/1 | Bryant Ranch Prepack | None |
| 71335-2780 | Propafenone Hydrochloride | tablet, coated | 150 mg/1 | Bryant Ranch Prepack | None |
| 72162-1751 | Propafenone Hydrochloride | tablet, coated | 150 mg/1 | Bryant Ranch Prepack | None |
| 50090-4227 | Propafenone Hydrochloride | tablet, coated | 225 mg/1 | A-S Medication Solutions | None |
| 51407-016 | Propafenone Hydrochloride | tablet, coated | 225 mg/1 | Golden State Medical Supply, Inc. | None |
| 62559-231 | Propafenone Hydrochloride | tablet, coated | 225 mg/1 | ANI Pharmaceuticals, Inc. | None |
| 63629-1988 | Propafenone Hydrochloride | tablet, coated | 225 mg/1 | Bryant Ranch Prepack | None |
| 72162-1752 | Propafenone Hydrochloride | tablet, coated | 225 mg/1 | Bryant Ranch Prepack | None |
| 51407-017 | Propafenone Hydrochloride | tablet, coated | 300 mg/1 | Golden State Medical Supply, Inc. | None |
| 62559-232 | Propafenone Hydrochloride | tablet, coated | 300 mg/1 | ANI Pharmaceuticals, Inc. | None |
| 63629-1989 | Propafenone Hydrochloride | tablet, coated | 300 mg/1 | Bryant Ranch Prepack | None |
| 63629-9280 | Propafenone Hydrochloride | tablet, coated | 300 mg/1 | Bryant Ranch Prepack | None |
| 72162-1753 | Propafenone Hydrochloride | tablet, coated | 300 mg/1 | Bryant Ranch Prepack | None |
| 59651-256 | PROPAFENONE HYDROCHLORIDE | tablet, film coated | 150 mg/1 | Aurobindo Pharma Limited | None |
Showing 40 of 53 listings.
Questions
Is propafenone a controlled substance?
No. Propafenone is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and propafenone is not on the DEA controlled substances list.
Is propafenone a narcotic?
No. Propafenone is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Antiarrhythmic.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.